Copyright Reports & Markets. All rights reserved.

Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Nucleic Acid Drugs Market Size 2022-2028
    • 2.1.2 Nucleic Acid Drugs Market Size CAGR by Region
  • 2.2 Nucleic Acid Drugs Segment by Type
    • 2.2.1 Antisense Nucleic Acid Drugs
    • 2.2.2 siRNA Drugs
    • 2.2.3 saRNA Drugs
    • 2.2.4 miRNA Drugs
    • 2.2.5 mRNA Drugs
    • 2.2.6 other
  • 2.3 Nucleic Acid Drugs Market Size by Type
    • 2.3.1 Global Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)
    • 2.3.2 Global Nucleic Acid Drugs Market Size Growth Rate by Type (2022-2028)
  • 2.4 Nucleic Acid Drugs Segment by Application
    • 2.4.1 Genetic Disease
    • 2.4.2 Cancer
    • 2.4.3 Cardiovascular Diseases
    • 2.4.4 Other
  • 2.5 Nucleic Acid Drugs Market Size by Application
    • 2.5.1 Global Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)
    • 2.5.2 Global Nucleic Acid Drugs Market Size Growth Rate by Application (2022-2028)

3 Nucleic Acid Drugs Key Players

  • 3.1 Date of Key Players Enter into Nucleic Acid Drugs
  • 3.2 Key Players Nucleic Acid Drugs Product Offered
  • 3.3 Key Players Nucleic Acid Drugs Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Nucleic Acid Drugs Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Nucleic Acid Drugs by Regions

  • 4.1 Nucleic Acid Drugs Market Size by Regions (2022-2028)
  • 4.2 United States Nucleic Acid Drugs Market Size Growth (2022-2028)
  • 4.3 China Nucleic Acid Drugs Market Size Growth (2022-2028)
  • 4.4 Europe Nucleic Acid Drugs Market Size Growth (2022-2028)
  • 4.5 Rest of World Nucleic Acid Drugs Market Size Growth (2022-2028)

5 United States

  • 5.1 United States Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 5.2 United States Nucleic Acid Drugs Market Size by Application (2022-2028)

6 China

  • 6.1 China Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 6.2 China Nucleic Acid Drugs Market Size by Application (2022-2028)

7 Europe

  • 7.1 Europe Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 7.2 Europe Nucleic Acid Drugs Market Size by Application (2022-2028)

8 Rest of World

  • 8.1 Rest of World Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 8.2 Rest of World Nucleic Acid Drugs Market Size by Application (2022-2028)
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Key Investors in Nucleic Acid Drugs

  • 10.1 Company A
    • 10.1.1 Company A Company Details
    • 10.1.2 Company Description
    • 10.1.3 Companies Invested by Company A
    • 10.1.4 Company A Key Development and Market Layout
  • 10.2 Company B
    • 10.2.1 Company B Company Details
    • 10.2.2 Company Description
    • 10.2.3 Companies Invested by Company B
    • 10.2.4 Company B Key Development and Market Layout
  • 10.3 Company C
    • 10.3.1 Company C Company Details
    • 10.3.2 Company Description
    • 10.3.3 Companies Invested by Company C
    • 10.3.4 Company C Key Development and Market Layout
  • 10.4 Company D
  • 10.5 ……

11 Key Players Analysis

  • 11.1 Sarepta Therapeutics
    • 11.1.1 Sarepta Therapeutics Company Details
    • 11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
    • 11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.1.4 Sarepta Therapeutics Main Business Overview
    • 11.1.5 Sarepta Therapeutics News
  • 11.2 Ionis Pharmaceuticals
    • 11.2.1 Ionis Pharmaceuticals Company Details
    • 11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
    • 11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.2.4 Ionis Pharmaceuticals Main Business Overview
    • 11.2.5 Ionis Pharmaceuticals News
  • 11.3 Alnylam
    • 11.3.1 Alnylam Company Details
    • 11.3.2 Alnylam Nucleic Acid Drugs Product Offered
    • 11.3.3 Alnylam Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.3.4 Alnylam Main Business Overview
    • 11.3.5 Alnylam News
  • 11.4 Mina Therapeutics
    • 11.4.1 Mina Therapeutics Company Details
    • 11.4.2 Mina Therapeutics Nucleic Acid Drugs Product Offered
    • 11.4.3 Mina Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.4.4 Mina Therapeutics Main Business Overview
    • 11.4.5 Mina Therapeutics News
  • 11.5 BioNTech
    • 11.5.1 BioNTech Company Details
    • 11.5.2 BioNTech Nucleic Acid Drugs Product Offered
    • 11.5.3 BioNTech Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.5.4 BioNTech Main Business Overview
    • 11.5.5 BioNTech News
  • 11.6 NeXstar Pharmaceuticals
    • 11.6.1 NeXstar Pharmaceuticals Company Details
    • 11.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offered
    • 11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.6.4 NeXstar Pharmaceuticals Main Business Overview
    • 11.6.5 NeXstar Pharmaceuticals News
  • 11.7 Nippon Shinyaku
    • 11.7.1 Nippon Shinyaku Company Details
    • 11.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
    • 11.7.3 Nippon Shinyaku Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.7.4 Nippon Shinyaku Main Business Overview
    • 11.7.5 Nippon Shinyaku News
  • 11.8 Moderna Therapeutics
    • 11.8.1 Moderna Therapeutics Company Details
    • 11.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
    • 11.8.3 Moderna Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.8.4 Moderna Therapeutics Main Business Overview
    • 11.8.5 Moderna Therapeutics News
  • 11.9 CureVac
    • 11.9.1 CureVac Company Details
    • 11.9.2 CureVac Nucleic Acid Drugs Product Offered
    • 11.9.3 CureVac Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.9.4 CureVac Main Business Overview
    • 11.9.5 CureVac News
  • 11.10 Regulus Therapeutics
    • 11.10.1 Regulus Therapeutics Company Details
    • 11.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
    • 11.10.3 Regulus Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.10.4 Regulus Therapeutics Main Business Overview
    • 11.10.5 Regulus Therapeutics News
  • 11.11 Miragen Therapeutics

12 Research Findings and Conclusion

According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.

Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other

Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Buy now